Tuesday, November 6, 2018
Diplomat Pharmacy raises FY18 EPS view to (10c)-3c from (15c)-1c
Raises upper end of FY18 revenue view to $5.5B-$5.7B from $5.5B-$5.9B. Consensus is for FY18 EPS 83c and for revenue $5.64B. Sees net income attributable to Diplomat between ($7.5M)-$2.6M; and adjusted EBITDA $164M-$170M.
https://thefly.com/landingPageNews.php?id=2818967
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.